Abstract
Aeromonas dhakensis is an increasingly recognized human pathogen in recent years and was first isolated and reported in a sample of childhood diarrhea in Bangladesh. More and more cases of Aeromonas dhakensis infection have been reported in recent years. Here we report a case of severe pneumonia caused by Aeromonas dhakensis with severe atrial septal defect. The patient, a 56-year-old male, was admitted to the hospital with severe hypoxemia and severe septic shock. Detection of the patient's bronchoalveolar lavage fluid (BALF) and peripheral blood by the metagenomic next generation sequencing (mNGS) indicated Aeromonas dhakensis infection.
Introduction
Aeromonas dhakensis, a Gram-negative bacterium typically found in freshwater environments, is emerging as a highly virulent human pathogen. It is frequently associated with rapid-onset sepsis and multiple organ failure, carrying a 14-day mortality rate of approximately 25.5%. A significant clinical challenge is its frequent misidentification as A. hydrophila in standard laboratory settings, which can delay appropriate treatment.
This case explores a "perfect storm" of hyper-virulent infection in a 56-year-old male with a long-standing, severe congenital heart defect: a 2.66 cm atrial septal defect (ASD). The presence of the ASD created a significant pulmonary shunt, rendering traditional mechanical ventilation insufficient and complicating the hemodynamic management of septic shock.
Case Presentation and Diagnostic Methods
The patient presented with severe respiratory failure and septic shock. To navigate the diagnostic hurdles of rare pathogens, clinicians employed a multi-faceted approach:
- Metagenomic Next-Generation Sequencing (mNGS): Using the Illumina MiSeq platform, DNA from bronchoalveolar lavage fluid (BALF) and peripheral blood was sequenced. This provided a definitive identification of A. dhakensis by the third day of hospitalization, showing a 95.68% relative abundance.
- Advanced Imaging: Chest X-rays and CT scans were utilized to monitor the progression of the bilateral lung infection and subsequent interstitial changes.
- Hemodynamic Management: Echocardiography confirmed a massive 2.66 cm ASD. This defect allowed deoxygenated blood to bypass the lungs due to high pulmonary pressure, necessitating a specialized Veno-Arterio-Veno Extracorporeal Membrane Oxygenation (VAV-ECMO) configuration to provide both respiratory support and circulatory stability.
Therapeutic Intervention
Based on mNGS results and drug sensitivity testing, the patient was treated with a combination of omadacycline and imipenem. To manage severe pulmonary hypertension (reaching 80 mmHg), clinicians administered sildenafil, ambrisentan, and inhaled nitric oxide (NO).
Key Insights
- Virulence Factors: A. dhakensis is significantly more dangerous than other Aeromonas species due to cytotoxic enterotoxins and exotoxin A, which can rapidly deplete blood cell lines and cause systemic organ failure. This was evidenced by the patient's procalcitonin levels reaching 91.8 ng/mL.
- The Shunt Complication: The patient’s 30-year history of ASD meant that pneumonia-induced pulmonary pressure forced blood through the cardiac defect, bypassing the lungs. This explains the persistent hypoxemia that standard ECMO could not resolve, requiring the VAV-ECMO setup.
- Antibiotic Resistance: A. dhakensis often carries $\beta$-lactamases, making it resistant to many common penicillins and cephalosporins. This case highlights the danger of using cephalosporin monotherapy for suspected Aeromonas infections.
Results and Conclusion
Despite the high-mortality risk associated with both the pathogen and the cardiac complication, the patient was successfully weaned from the ventilator after two months of intensive care. While the patient survived, the infection resulted in permanent pulmonary interstitial changes.
This case underscores the vital role of mNGS in identifying emerging pathogens and the necessity of tailored ECMO configurations in patients with complex congenital heart disease. Future research is required to standardize rapid diagnostic protocols and determine optimal antibiotic combinations to combat the natural resistance mechanisms of A. dhakensis.
Summary updated